SCHEMBL7323835

SCHEMBL7323835

C=CCC(CCC)[N+](=O)[O-]

nearest known ligand 0.40

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CPA1 P15085 1/20 0.40
ALDH1A1 P00352 1/20 0.32
MMP9 P14780 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11414624 0.85 ALDH1A1 (0.39) CPA1ALDH1A1
SCHEMBL28195500 0.83
SCHEMBL1170239 0.79 ALDH1A1 (0.42) ALDH1A1
SCHEMBL2801476 0.76
SCHEMBL1118146 0.75
SCHEMBL28141644 0.75 ALDH1A1 (0.33) ALDH1A1
SCHEMBL27686258 0.73 ALDH1A1 (0.38) ALDH1A1
SCHEMBL10402405 0.72 CPA1 (0.35) CPA1
SCHEMBL1151111 0.71 ALDH1A1 (0.42) ALDH1A1
SCHEMBL27709392 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-3118361-A None JP disclosed
WO-2015106443-A1 PREPARATION AND APPLICATION OF BIPHENYL COMPOUND 迈克斯(如东)化工有限公司 2015-07-23 WO disclosed
EP-2276756-B9 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2012-08-15 EP disclosed
EP-2276756-B1 HYDROXYMETHYL PYRROLIDINES AS BETA 3 ADRENERGIC RECEPTOR AGONISTS MERCK SHARP & DOHME (US) 2011-11-30 EP disclosed
US-5444083-A DOPAMINE AGONIST FOR TREATING OR PREVENTION OF HYPERTENSION OR HEART FAILURE EISAI CO., LTD. (JP) 1995-08-22 US disclosed
EP-0381235-B1 PYRROLIDINE COMPOUND AND PHARMACEUTICAL USE Eisai Co., Ltd. (JP) 1993-07-28 EP disclosed
JP-H03118361-A PYRROLIDINE DERIVATIVE EISAI CO LTD 1991-05-20 JP disclosed
EP-0381235-A2 Pyrrolidine compound and pharmaceutical use Eisai Co., Ltd. (JP) 1990-08-08 EP disclosed